SCOPUS 정보 검색 플랫폼

Breast Cancer Research and Treatment

Volumn 30, Issue 2, 1994, Pages 117-126

Do we really need prognostic factors for breast cancer?

(1) Clark, Gary M a

a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO (United States)

Author keywords

cutpoint analysis; drug resistance; markers; multivariate models; prognostic factors; prognostic indexes; validation

Indexed keywords

TUMOR MARKER;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG RESISTANCE; HIGH RISK POPULATION; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; TUMOR MODEL;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DRUG RESISTANCE; FEMALE; HUMAN; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0028048359 PISSN: 01676806 EISSN: 15737217 Source Type: Journal
DOI: 10.1007/BF00666054 Document Type: Article

Times cited : (77)

References (20)

1
- 0003193675
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
- Early Breast Cancer Trialists' Collaborative Group
- (1992) Lancet , vol.339 , pp. 1-15

2
- 84936043854
- Anonymous: NIH Consensus Conference. Treatment of early-stage breast cancer. J Am Med Assoc 265: 391-395, 1991.

3
- 0024533068
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
- (1989) Cancer , vol.63 , pp. 181-187
- Carter, C.L.¹ Allen, C.² Henson, D.E.³

4
- 0025923350
- Prognosis in T2M0N0 stage I breast carcinoma: a 20-year follow-up study
- (1991) J Clin Oncol , vol.9 , pp. 1650-1661
- Rosen, P.P.¹ Groshen, S.² Kinne, D.W.³

5
- 0026558685
- Breast cancer treatment and natural history: new insights from results of screening
- (1992) Lancet , vol.339 , pp. 412-414
- Tabar, L.¹ Fagerberg, G.² Day, N.E.³

6
- 0026639108
- Prognostic factors and treatment decisions in node-negative breast cancer
- (1992) N Engl J Med , vol.326 , pp. 1756-1761
- McGuire, W.L.¹ Clark, G.M.²

7
- 0020031067
- A prognostic index in primary breast cancer
- (1982) Br J Cancer , vol.45 , pp. 361-366
- Haybittle, J.L.¹ Blamey, R.W.² Elston, C.W.³

8
- 0026808390
- The Nottingham Prognostic Index in primary breast cancer
- (1992) Breast Cancer Res Treat , vol.22 , pp. 207-219
- Galea, M.H.¹ Blamey, R.W.² Elston, C.W.³ Ellis, I.O.⁴

9
- 0026801393
- Why do so many prognostic factors fail to pan out?
- (1992) Breast Cancer Res Treat , vol.22 , pp. 197-206
- Hilsenbeck, S.G.¹ Clark, G.M.² McGuire, W.L.³

10
- 0027503365
- Heat shock protein hsp70 with axillary lymph node-negative breast cancer patients: prognostic implications
- (1993) J Natl Cancer Inst , vol.85 , pp. 570-574
- Ciocca, D.R.¹ Tandon, A.K.² Fuqua, S.A.W.³

11
- 0027073288
- Evaluation of cathepsin D as a prognostic factor in breast cancer
- (1993) Breast Cancer Res Treat , vol.24 , pp. 219-226
- Ravdin, P.M.¹

12
- 0026689783
- Prognostic factors for breast cancer: have they met their promise?
- (1992) J Clin Oncol , vol.10 , pp. 679-682
- Osborne, C.K.¹

13
- 0027461886
- How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer
- (1993) Cancer , vol.71 , pp. 2157-2162
- Clark, G.M.¹ Wenger, C.R.² Beardslee, S.³

14
- 37049183697
- Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
- (1987) Science , vol.235 , pp. 177-182
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³

15
- 0026019357
- Follow-up study of HER-2/neu amplification in primary breast cancer
- (1991) Cancer Res , vol.51 , pp. 944-948
- Clark, G.M.¹ McGuire, W.L.²

16
- 0026576399
- HER-2/neu in node-negative breast cancer. Prognostic significance of overexpression influenced by presence of in situ carcinoma
- (1992) J Clin Oncol , vol.10 , pp. 599-605
- Allred, D.C.¹ Clark, G.M.² Tandon, A.K.³

17
- 0026625217
- Prognostic importance of c-erbB-2 expression in breast cancer
- (1992) J Clin Oncol , vol.10 , pp. 1049-1056
- Gusterson, B.A.¹ Gelber, R.D.² Goldhirsch, A.³

18
- 8044223820
- erbB-2 (c-cerbB-2; HER-2/neu) and S-phase fraction predict response to adjuvant chemotherapy in patients with node-positive breast cancer: Cancer and Acute Leukemia Group B Trial 8869
- (1993) Proc ASCO , vol.12 , pp. 72
- Muss, H.¹ Thor, A.² Kute, T.³

19
- 0026623042
- Response of human breast cancer cells to heat shock and chemotherapeutic drugs
- (1992) Cancer Res , vol.52 , pp. 3648-3654
- Ciocca, D.R.¹ Fuqua, S.A.W.² Lock-Lim, S.³

20
- 84936030354
- Oesterreich S, Weng C-N, Qiu M, et al: The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res, in press.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.